Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Report Scope:

The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.

Report Includes:

26 data tables and 28 additional tables

An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry

Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market

Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region

Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc.

Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds

Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry

Review of selected patents and patent applications on organoids, and emerging developments in the global market

Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

Descriptive company profiles of the leading Organoids market players, including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB), and STEMCELL Technologies Inc.

Companies Mentioned

3d Biotek Llc
3dnamics Inc.
Advanced Biomatrix Inc.
Alpha Genesis Inc.
Aspect Biosystems Ltd.
Bioink Solutions Inc.
Cellink Inc.
Charles River Laboratories International Inc.
Cincinnati Children’s Hospital Medical Center
Collplant Holdings Ltd.
Corning Inc.
Crown Bioscience
East River Biosolutions/Xylyx Bio
Emulate Inc.
Genoway S.A.
Horizon Discovery Ltd.
Hubrecht Organoid Technology (Hub)
Insphero Inc.
Janvier Labs
Kirkstall Ltd.
Labcorp Drug Development (Covance Inc.)
Mattek Corp.
Merck Kgaa
Micronit Microtechnologies
Nano 3d Biosciences Inc.
Oak Hill Genetics
Organovo Holdings Inc.
Pepgel Llc
Promocell Gmbh
R&D Systems Inc.
Reprocell Inc.
Stemcell Technologies Inc.
Synthecon Inc.
Taconic Biosciences
Tara Biosystems Inc.
Tevido Biodevices Inc.
The Jackson Laboratory
Thermo Fisher Scientific
Tissuse Gmbh
Transgenic Inc.
Transposagen Biopharmaceuticals Inc.
Trevigen Inc. (Bio-techne)

Chapter 1 Introduction
BackgroundStudy Goals And ObjectivesReasons For Doing This StudyScope Of ReportWhat's New In This Update?Information Sources And MethodologyGeographic BreakdownAnalyst's CredentialsBcc Custom ResearchRelated Bcc Research Reports
Chapter 2 Summary And Highlights
Chapter 3 Animal Model Market Technology Background
Methods Of Animal Model And 3d Cell Culture ModificationPhysical And Chemical MutationsTargeted MutationsOther TechnologiesLaboratory Animal ModelsMarket DefinitionAnimal Model LinesCommon Species Of Laboratory Animals
Chapter 4 Impact Of Covid-19 On The Global Market For Organoids
OverviewImpact Of Covid-19 On OrganoidsConclusion
Chapter 5 Market Dynamics
Market DriversIncreasing Emphasis On Developing Alternative Approaches To Animal TestingRising Demand For Tumor Modelling And Biobanking To Drive Market GrowthIncreasing Adoption Of The Organoid Technology For Wide Range Of ApplicationsMarket RestraintsStringent Government Regulatory Setting In Research And Development Of Cell Cultures And Stem CellsConcerns Associated With The Integration Of Organoids Into Current WorkflowsMarket OpportunitiesIncreasing Applications Of Organoids In Drug Development, Personalized Medicine And Transplantational Medicine
Chapter 6 3d Cell Technology Background
3d Cell CulturesSpheroids2d Cultures Vs. 2.5d Cultures Vs. 3d CulturesScaffold-based And Scaffold-free 3d Cell CulturesScaffold-free 3d Cell CulturesScaffold-based 3d Cell CulturesTissue Engineering And Bioprinting3d Bioprinting TechnologyTypes Of Bioprinting MethodsMicrofluidic Organ-on-chip PlatformsTypes Of Organ-on-chip Devices
Chapter 7 Market Breakdown By Organ Type
Global Market For Organoids, By Organ TypeIntestineMarket Size And ForecastLiverMarket Size And ForecastStomachMarket Size And ForecastPancreasMarket Size And ForecastLung (Pulmonary)Market Size And ForecastKidneyMarket Size And ForecastOthersCardiac OrganoidsCancer OrganoidsMarket Size And Forecast
Chapter 8 Market Breakdown By Application
Global Market For Organoids, By ApplicationDevelopmental BiologyMarket Size And ForecastDrug Discovery And Personalized MedicineMarket Size And ForecastRegenerative MedicineMarket Size And ForecastPathology Of Infectious DiseaseMarket Size And ForecastDrug Toxicity And Efficacy TestingMarket Size And Forecast
Chapter 9 Market Breakdown By Region
Global Market For Organoids, By RegionNorth AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalySpainRest Of EuropeAsia-pacificChinaJapanAustraliaIndiaRest Of Asia-pacificRest Of The WorldMarket Size And Forecast
Chapter 10 Patent Review/New Developments
Chapter 11 Analysis Of Market Opportunities
Market Opportunities: Animal ModelsMarket Opportunities: 3d Cell Culture SegmentOrgans-on-chipOrganoidsBioprintingAdvantages And Disadvantages Of 3d Cell Cultures And Animal ModelsAnimal Models3d Cell Cultures In GeneralOrganoidsOrgans-on-chip
Chapter 12 Competitive Landscape
Chapter 13 Profiles Of Companies And Important Institutions
Animal Model CompaniesAlpha Genesis Inc.Charles River Laboratories International Inc.EnvigoGenoway S.A.Labcorp Drug Development (Covance Inc.)The Jackson LaboratoryJanvier LabsOak Hill GeneticsPrimgenTaconic BiosciencesTransgenic Inc.Transposagen Biopharmaceuticals Inc.Bioprinting And Regenerative Medicine CompaniesAlleviAspect Biosystems Ltd.Bioink Solutions Inc.Cellink Inc.Collplant Holdings Ltd.East River Biosolutions/Xylyx BioEpiboneMattek Corp.Nano 3d Biosciences Inc.Organovo Holdings Inc.Pepgel LlcRegenhuTevido Biodevices Inc.Tissuse GmbhOrgan-on-chip CompaniesAxosimEmulate Inc.Kirkstall Ltd.Micronit MicrotechnologiesMimetasTara Biosystems Inc.Organoid Companies3dnamics Inc.CellesceCincinnati Children’s Hospital Medical CenterCrown BioscienceCorning Inc.DefinigenHubrecht Organoid Technology (Hub)Merck KgaaR&D Systems Inc.Stemcell Technologies Inc.Thermo Fisher ScientificTrevigen Inc. (Bio-techne)Other 3d Cell Culture Companies3d Biotek LlcAdvanced Biomatrix Inc.Horizon Discovery Ltd.Insphero Inc.Promocell GmbhReprocell Inc.Synthecon Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings